Canada markets closed

OncoCyte Corporation (OCX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.4800+0.0400 (+1.64%)
At close: 04:00PM EDT
2.5800 +0.10 (+4.03%)
After hours: 04:39PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
8,097
1,503
958
2,198
1,216
Cost of Revenue
8,749
1,090
976
778
1,855
Gross Profit
-652
413
-18
1,420
-639
Operating Expenses
Research Development
19,714
9,294
7,301
5,035
9,800
Selling General and Administrative
36,913
13,536
21,533
20,392
23,282
Total Operating Expenses
56,627
22,830
28,834
25,427
33,082
Operating Income or Loss
-57,279
-22,417
-28,852
-24,007
-33,721
Interest Expense
302
52
83
209
252
Total Other Income/Expenses Net
-6,326
-2,386
10,323
-28,655
2,787
Income Before Tax
-63,712
-24,855
-18,612
-52,871
-31,186
Income Tax Expense
97
-
0
-9,261
-1,254
Income from Continuing Operations
-63,809
-24,855
-18,612
-43,610
-29,932
Net Income
-63,809
-27,781
-72,902
-64,097
-29,932
Net Income available to common shareholders
-64,103
-28,723
-73,422
-64,097
-29,932
Basic EPS
-9.66
-3.75
-13.25
-14.40
-9.20
Diluted EPS
-9.66
-3.75
-13.25
-14.40
-9.20
Basic Average Shares
7,069
7,651
5,540
4,446
3,274
Diluted Average Shares
7,069
7,651
5,540
4,446
3,274